Skip to main content
Clinical Trials/NCT05466383
NCT05466383RecruitingNot Applicable

Screening and Intervention for Adolescent Idiopathic Scoliosis in Haikou, Hainan Province, China

Chaoyin Jiang1 site in 1 country5,000 target enrollmentStarted: October 24, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
5,000
Locations
1
Primary Endpoint
Out-of-control rate of treatment

Study Overview

Brief Summary

This is a single-center, prospective, non-randomized, open-label, interventional, real-world study. The mild/moderate AIS patients will be recruited through screening of 250,000 primary and secondary school students in Haikou, Hainan Province. The patients will be treated with different non-surgical interventions (exercise intervention or brace intervention) according to the physician's recommendations and the patient's intention. Patients will be followed up for 36 months to evaluate the effectiveness and safety of non-surgical interventions in the real world.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Sequential
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
9 Years to 16 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •9 years ≤ age ≤ 16 years
  • •Diagnosis of AIS
  • •10°≤Cobb's angle<45°
  • •Signed informed consent form

Exclusion Criteria

  • •With other developmental disorders, musculoskeletal disorders, nerve disorders, infection disorders, mental disorders, and other disorders
  • •Obvious deformity of lower limbs and(or) feet
  • •Previous or ongoing treatment of AIS
  • •Difficulty to read, understanding, and complete the study questionnaires
  • •Any criteria, which, in the opinion of the investigator, suggest that the subject would not be compliant with this study protocol

Arms & Interventions

recommend exercise - perference brace

Active Comparator

Intervention: Brace (Device)

recommend exercise - perference observation

No Intervention

recommend brace - perference brace

Active Comparator

Intervention: Brace (Device)

recommend brace - perference exercise

Active Comparator

Intervention: Exercise (Behavioral)

recommend brace - perference observation

No Intervention

recommend exercise - perference exercise

Active Comparator

Intervention: Exercise (Behavioral)

Outcomes

Primary Outcomes

Out-of-control rate of treatment

Time Frame: 36 months

Among the patients with skeletal immaturity (Risser's sign 0, 1, 2), out-of-control rate of treatment at the follow-up to 36 months or at skeletal maturity during the trial (i.e., 4° for female Risser's sign or 5° for male Risser's sign). Out-of-control rate of treatment is defined as either: Cobb angle progression \>5°, or Cobb angle ≥45°, or the physician recommends or already has enhanced the intervention regimen (i.e., no intervention change to exercise intervention, no intervention change to brace intervention, or exercise intervention change to brace intervention).

Secondary Outcomes

  • Correlation between the treatment compliance and the out-of-control rate of treatment(36 months)
  • Correlation between the skeletal maturity at baseline and the out-of-control rate of treatment(36 months)
  • Correlation between the skeletal maturity at baseline and the change in 36-month Cobb angle from baseline(36 months)
  • Change in SRS-22 score from baseline over time(at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment)
  • Change in plantar pressure from baseline over time(at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment)
  • Change in gait from baseline over time(at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment)
  • Correlation between the immediate correction and the out-of-control rate of treatment(36 months)
  • Correlation between the treatment compliance and the change in 36-month Cobb angle from baseline(36 months)
  • Correlation between the immediate correction and the change in 36-month Cobb angle from baseline(36 months)
  • Correlation between the Cobb's angle at baseline and the change in 36-month Cobb angle from baseline(36 months)
  • Change in vital capacity from baseline over time(at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment)
  • Correlation between the Cobb's angle at baseline and the out-of-control rate of treatment(36 months)
  • The change in Cobb angle from baseline over time(36 months)
  • The incidence of adverse events(36 months)

Investigators

Sponsor
Chaoyin Jiang
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Chaoyin Jiang

Professor

Shanghai 6th People's Hospital

Study Sites (1)

Loading locations...

Similar Trials

Screening and Intervention for AIS in... | Clinical Trial